DISPATCHES FROM INTERPHEX

AlpVision's iPhone Tech Offers Authentication in War on Counterfeits

Loading the player...

In the war against counterfeits, regulators have concentrated on serialisation and ePedigree and missed an opportunity on product authentication, according to AlpVision.

The company was at this year’s Interphex and Regional Manager Quincy Mattingly spoke to in-Pharmatechnologist.com regarding its new mobile authentication solution for pharmaceutical anti-counterfeiting.

Mattingley said his company’s technology was being used by some of the top 50 pharma companies in emerging markets such as Africa and Asia.

The system uses an iPhone to detect AlpVision's Cryptoglyph and Fingerprint covert safety features, the former relying on invisible markings on packaging and the latter based on digital images of the original product stored in a secure server.

This is not the first time mobile phones have been used in the fight against counterfeit drugs. A scheme led by GlaxoSmithKline in Nigeria was implemented in 2011 to send users a confirmation code of drug authenticity by text message.

However, Mattingly told us there is a danger this SMS verification code “could be copied by counterfeiters” as it is a visible form of authentication, whilst AlpVision’s technology proposes a verification process that requires no visible markings, additional consumables, special reading devices or production changes other than a smartphone.

When asked about his views on ePedigree, the ongoing track-and-trace legislation, Mattingly said he thought regulators have “missed a mark on product authentication because serialisation doesn’t guarantee that your product is authentic.”

Related News

New in-PharmaTechnologist.com App available

If You’re App-y Now You’ll Know It With Our New iPhone Widget

Don't Worry, Be App-y With OSP's New iPhone Widget

Concerned About Missing the News? Don't Worry, Be App-y With OSP's New iPhone Widget

Edible Silica Microtags: Eating Away at Counterfeit Drugs

US set for track and trace

US set for track and trace after Senate passes quality and security Bill

MHRA and Novartis lead consortium to develop adverse drug reaction app

MHRA and Novartis lead consortium to develop adverse drug reaction app

Image: iStock/Rawpixel Ltd

Serialisation regulations to impact all corners of pharma, says Recipharm

Contract packagers must adapt to surge in serialisation

Contract packagers must adapt to surge in serialisation

Systech & Zetes partner to meet EU serialisation needs

Systech’s T&T system wins ‘top 10’ pharma customer in Brazil

Track and trace in pharmaceuticals: Mettler Toledo

Mettler Toledo take track and trace offering to the US

FDA wants standardised drug pack numbering